Investigating Predictive Factors of Pathological Complete Response After Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer.

Background: Standard treatment for locally advanced rectal cancer (LARC) includes neoadjuvant chemoradiotherapy (CRT) followed by surgery and adjuvant chemotherapy. Although achieving a pathological complete response (pCR) is considered a favorable prognostic factor, the parameters influencing pCR r...

Descripción completa

Detalles Bibliográficos
Publicado en:International Journal of Cancer Management Vol. 18; no. 1; pp. 1 - 8
Autores principales: Rakhsha, Afshin, Khandani, Maryam Kalantari, Shokri, Fateme
Formato: research tables/charts Journal Article
Publicado: Medical Journals Commission of the Ministry of Health & Medical Education Jan-Dec2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=191502730&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 191502730
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        25384422
        L6AI
      jtl: International Journal of Cancer Management
      issn: 25384422
      maglogo: N
    pubinfo:
      dt: Jan-Dec2025
      vid: 18
      iid: 1
      pid: 66482
      pub: Medical Journals Commission of the Ministry of Health & Medical Education
    artinfo:
      ui:
        191502730
        191502730
        191502730
        10.5812/ijcm-159417
        191502730
      ppf: 1
      ppct: 7
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Investigating Predictive Factors of Pathological Complete Response After Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer.
      aug:
        au:
          Rakhsha, Afshin
          Khandani, Maryam Kalantari
          Shokri, Fateme
        affil: Cancer Research Center, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
      sug:
        subj:
          Rectal Neoplasms Pathology
          Rectal Neoplasms Radiotherapy
          Cancer Patients Psychosocial Factors
          Neoadjuvant Therapy
          Pathologic Complete Response
          Predictive Value of Tests
          Treatment Outcomes Evaluation
          Human
          Male
          Female
          Academic Medical Centers
          Cross Sectional Studies
          Quantitative Studies
          Analytic Research
          Retrospective Design
          Chi Square Test
          T-Tests
          Fisher's Exact Test
          Neoplasm Staging
          Chemoradiotherapy
          Male
          Female
      ab: Background: Standard treatment for locally advanced rectal cancer (LARC) includes neoadjuvant chemoradiotherapy (CRT) followed by surgery and adjuvant chemotherapy. Although achieving a pathological complete response (pCR) is considered a favorable prognostic factor, the parameters influencing pCR remain incompletely defined. Objectives: This study investigated predictive factors for achieving pCR in patients with LARC who underwent neoadjuvant CRT. Methods: This retrospective cross-sectional study included 100 patients with LARC who underwent neoadjuvant CRT between May 2018 and September 2023 at Shohadaye Tajrish Hospital, Tehran, Iran. Patients' demographics, clinicopathological data, and treatment details, including chemotherapy and radiotherapy data, were reviewed to analyze their correlation with pCR. Statistical analysis was performed using the chi-square test, Student's t-test, and Fisher's exact test to assess factors associated with pCR. A P-value of < 0.05 was considered statistically significant. Results: Pathological complete response was obtained in 28% of the cases. Clinical stage and induction chemotherapy were independent predictors of pCR (P < 0.05). Patients with T3N1 and T3N2 stages had higher pCR rates, whereas none of the T4N2 patients achieved pCR. The number of induction chemotherapy cycles was strongly associated with pCR. The pCR rates were significantly higher for those patients who received four cycles or more (P < 0.05). No significant association was found between pCR and age, gender, Body Mass Index (BMI), tumor differentiation, or radiotherapy dosimetry. Conclusions: The clinical stage at diagnosis and the extent of induction chemotherapy were significant predictors of pCR in this study. Further prospective studies are warranted to validate these findings and explore additional predictive factors.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N